Catalyst Wire Dossier Catalyst Wire Dossier

BREO ELLIPTA

fluticasone furoate and vilanterol trifenatate · GlaxoSmithKline LLC
Drug timelines are a Plus or Pro feature.

21 regulatory and trial events tracked for BREO ELLIPTA, covering 2013-05-10 to 2023-05-12. Get the full timeline:

Most recent: FDA Approved: BREO ELLIPTA — Supplemental Application (GlaxoSmithKline LLC)

See pricing